Skip to main content
Clinical Trials/NL-OMON29757
NL-OMON29757Not yet recruitingNot Applicable

Radiolabeled bevacizumab as a tracer of VEGF expression in patients with colorectal liver metastases - Avastin-scanning in patients with colorectal liver metastases

niversitair Medisch Centrum Sint Radboud0 sites10 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Colorectal liver metastases, planned surgical resection within 6 weeks.

Exclusion Criteria

  • Pregnancy, lactation, recent chemotherapy (within 3 months after last chemotherapy regimen).

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Similar Trials